| Line Item | 2022-05-31 | Y/Y |
|---|---|---|
| Revenue | $42.44B | +4.8% |
| R&D Expense | $7.22B | +10.6% |
| SG&A Expense | $1.32B | +5.0% |
| Operating Income | $10.93B | -28.2% |
| Interest Expense | $2.75B | +10.4% |
| Income Tax | $932.0M | +224.8% |
| Net Income | $6.72B | -51.1% |
| EPS (Basic) | $2.49 | -46.7% |
| EPS (Diluted) | $2.41 |
| Line Item | 2022-05-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $21.38B | -29.0% |
| Accounts Receivable | $5.95B | +10.1% |
| Inventory | $314.0M | +121.1% |
| Current Assets | $31.63B | -43.1% |
| Total Assets | $109.30B | -16.6% |
| Current Liabilities | $19.51B | -19.3% |
| Long-term Debt | $0 | — |
| Line Item | 2022-05-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $9.54B | -40.0% |
| Capital Expenditures | $4.51B | +111.3% |
| Investing Cash Flow | $11.22B | +185.7% |
| Financing Cash Flow | -$29.13B | -180.7% |
| Free Cash Flow | $5.03B | -63.4% |
| -47.0% |
| Stockholders' Equity |
| -$6.22B |
| -218.7% |